PT1054666E - Formulacao farmaceutica liquida contendo zotepina - Google Patents

Formulacao farmaceutica liquida contendo zotepina

Info

Publication number
PT1054666E
PT1054666E PT99907436T PT99907436T PT1054666E PT 1054666 E PT1054666 E PT 1054666E PT 99907436 T PT99907436 T PT 99907436T PT 99907436 T PT99907436 T PT 99907436T PT 1054666 E PT1054666 E PT 1054666E
Authority
PT
Portugal
Prior art keywords
zotepin
liquid pharmaceutical
formula containing
pharmaceutical formula
liquid
Prior art date
Application number
PT99907436T
Other languages
English (en)
Inventor
Ann Margaret Dyer
Alan Smith
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of PT1054666E publication Critical patent/PT1054666E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT99907436T 1998-02-07 1999-01-27 Formulacao farmaceutica liquida contendo zotepina PT1054666E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
PT1054666E true PT1054666E (pt) 2003-03-31

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99907436T PT1054666E (pt) 1998-02-07 1999-01-27 Formulacao farmaceutica liquida contendo zotepina

Country Status (25)

Country Link
US (1) US6239165B1 (pt)
EP (1) EP1054666B1 (pt)
JP (1) JP2002502818A (pt)
KR (1) KR20010040717A (pt)
AR (1) AR018062A1 (pt)
AT (1) ATE227988T1 (pt)
AU (1) AU2720099A (pt)
BG (1) BG104682A (pt)
BR (1) BR9907644A (pt)
CA (1) CA2320475A1 (pt)
CO (1) CO4970815A1 (pt)
CZ (1) CZ291975B6 (pt)
DE (1) DE69904021T2 (pt)
DK (1) DK1054666T3 (pt)
ES (1) ES2188135T3 (pt)
GB (1) GB9802617D0 (pt)
HK (1) HK1033088A1 (pt)
HR (1) HRP20000579A2 (pt)
HU (1) HUP0100769A3 (pt)
PL (1) PL342213A1 (pt)
PT (1) PT1054666E (pt)
SK (1) SK11472000A3 (pt)
TR (1) TR200002288T2 (pt)
WO (1) WO1999039709A1 (pt)
ZA (1) ZA99918B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO129043B (pt) 1968-02-16 1974-02-18 Fujisawa Pharmaceutical Co
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
IL117612A0 (en) 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine
GB9526264D0 (en) 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
AU2720099A (en) 1999-08-23
HRP20000579A2 (en) 2001-04-30
ATE227988T1 (de) 2002-12-15
PL342213A1 (en) 2001-05-21
ZA99918B (en) 2000-08-07
HUP0100769A3 (en) 2002-04-29
CO4970815A1 (es) 2000-11-07
WO1999039709A1 (en) 1999-08-12
DK1054666T3 (da) 2003-03-17
HUP0100769A2 (hu) 2001-12-28
US6239165B1 (en) 2001-05-29
BR9907644A (pt) 2000-11-14
CZ20002846A3 (cs) 2000-12-13
HK1033088A1 (en) 2001-08-17
GB9802617D0 (en) 1998-04-01
JP2002502818A (ja) 2002-01-29
CA2320475A1 (en) 1999-08-12
TR200002288T2 (tr) 2000-12-21
SK11472000A3 (sk) 2001-08-06
BG104682A (en) 2001-05-31
EP1054666B1 (en) 2002-11-20
DE69904021T2 (de) 2003-04-30
EP1054666A1 (en) 2000-11-29
AR018062A1 (es) 2001-10-31
KR20010040717A (ko) 2001-05-15
ES2188135T3 (es) 2003-06-16
DE69904021D1 (de) 2003-01-02
CZ291975B6 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
DE69822346D1 (de) Flüssigkeitsverpackung
EE200000495A (et) Konteiner ravimvedeliku jaoks
PT853945E (pt) Formulacoes liquidas contendo gonadotrofina
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
DE60042589D1 (de) Flüssigkristallverbindungen
NO20030139L (no) Farmasöytiske preparater inneholdende DDS forbindelser
PT966952E (pt) Produtos liquidos contendo eritritol
AR028028A1 (es) Preparacion liquida estabilizada
NO20014926L (no) Farmasöytiske forbindelser
DE60008185D1 (de) Flüssigkristallzusammensetzung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ID30032A (id) Formulasi farmasi
DE69800559D1 (de) Ferrielektrische Flüssigkristallverbindung
PT1054666E (pt) Formulacao farmaceutica liquida contendo zotepina
DE69916615D1 (de) Flüssigformulierung
DE69901578T2 (de) Ferrielektrische Flüssigkristallverbindung
UA1584S (uk) Флакон для медичного препарату
FI981167A (fi) Nestepakkausmateriaali
DE69903784T2 (de) Ferrielektrische Flüssigkristallverbindung
FI990200A0 (fi) Nesteseostin
DE69901587D1 (de) Ferrielektrische Flüssigkristallverbindung
UA2164S (uk) Етикетка фармацевтичного засобу
UA2353S (uk) Етикетка фармацевтичного засобу